Global Messenger RNA Vaccines and Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Messenger RNA Vaccines and Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global Messenger RNA Vaccines and Therapeutics market size was valued at USD 10080 million in 2022 and is forecast to a readjusted size of USD 22370 million by 2029 with a CAGR of 12.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA to generate an immune response. [1] Such vaccines deliver antigen-coding mRNA molecules into immune cells, which use the designed mRNA as a template to build foreign proteins normally produced by pathogens such as viruses or cancer cells. These protein molecules stimulate an adaptive immune response, teaching the body to recognize and destroy the corresponding pathogen or cancer cell. mRNA is composed of RNA encapsulated in lipid nanoparticles, which protect the RNA strand and facilitate its uptake into cells. Reactogenicity, the propensity of the vaccine to produce adverse reactions, was similar to that of traditional non-RNA vaccines. People prone to autoimmune reactions may experience adverse reactions to messenger RNA vaccines. Compared with traditional vaccines, mRNA vaccines have the advantages of being easy to design, fast in production, low in cost, capable of inducing cellular and humoral immunity, and not interacting with genomic DNA.

This report is a detailed and comprehensive analysis for global Messenger RNA Vaccines and Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Messenger RNA Vaccines and Therapeutics market size and forecasts, in consumption value ($ Million), 2018-2029

Global Messenger RNA Vaccines and Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Messenger RNA Vaccines and Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Messenger RNA Vaccines and Therapeutics market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Messenger RNA Vaccines and Therapeutics

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Messenger RNA Vaccines and Therapeutics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioNTech, Moderna, CureVac, Pfizer and Glaxo Smith Kline's, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Messenger RNA Vaccines and Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Self-amplifying
Conventional Non-amplifying

Market segment by Application
Cancer
Infectious Diseases
Autoimmune Diseases
Others

Market segment by players, this report covers
BioNTech
Moderna
CureVac
Pfizer
Glaxo Smith Kline's
Daiichi Sankyo Company
Intellia Therapeutics
Arcturus Therapeutics
Emmy Vaccine
CSPC
CanSino
Fosun Pharma

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Messenger RNA Vaccines and Therapeutics product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Messenger RNA Vaccines and Therapeutics, with revenue, gross margin and global market share of Messenger RNA Vaccines and Therapeutics from 2018 to 2023.

Chapter 3, the Messenger RNA Vaccines and Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Messenger RNA Vaccines and Therapeutics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Messenger RNA Vaccines and Therapeutics.

Chapter 13, to describe Messenger RNA Vaccines and Therapeutics research findings and conclusion.